AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea · Delayed Price · Currency is KRW

25,050

+250 (1.01%)

At close: Jul 27, 2026

AprilBio Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	725.35	2,172	27,514	-	200	23,396
Revenue Growth	-97.56%	-92.11%	-	-	-99.15%	-
Gross Profit	701.89	2,149	27,498	-19.05	173.73	23,377
Operating Income	-9,346	-7,264	16,869	-13,388	-11,474	4,446
Net Income	-10,121	-9,728	20,005	-14,130	-8,959	-52,713
Earnings Per Share	-444.25	-429.34	913.00	-662.00	-458.00	-6322.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	82,942	92,771	94,482	63,587	68,784	54,377
Total Debt	440.09	497.99	3,106	5,904	311.26	347.82
Net Cash (Debt)	82,502	92,273	91,377	57,683	68,473	54,030
Net Cash Growth	-8.18%	0.98%	58.41%	-15.76%	26.73%	219.95%
Net Cash Per Share	3621.43	4072.41	4170.27	2702.58	3500.37	6479.89

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-4,066	-3,342	21,960	-10,059	-6,704	3,252
Capital Expenditures	-228.35	-287.84	-445.29	-511.97	-89.59	-705.82
Free Cash Flow	-4,294	-3,630	21,514	-10,571	-6,794	2,546
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	96.77%	98.94%	99.94%	-	86.87%	99.92%
Operating Margin	-1288.55%	-334.44%	61.31%	-	-5737.15%	19.00%
Pretax Margin	-1395.28%	-447.88%	72.71%	-	-4479.64%	-225.31%
Profit Margin	-1395.28%	-447.88%	72.71%	-	-4479.64%	-225.31%
FCF Margin	-591.99%	-167.14%	78.19%	-	-3396.76%	10.88%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	18.17	-	-	-
Forward PE	-	55.87	105.10	80.86	-	-
P/FCF Ratio	-	-	16.89	-	-	-
PS Ratio	737.58	586.62	13.21	-	926.73	-